Management of Hyponatremia in Neurosurgical Patients

Diagnosis and Differentiation

The critical factor in distinguishing between SIADH and CSW is determination of extracellular fluid volume status, with SIADH characterized by euvolemia and CSW presenting with hypovolemia 1, 2, 3
Laboratory criteria for SIADH include plasma osmolality <275 mOsm/kg, urine osmolality >100 mOsm/kg, and absence of hypothyroidism and hypocortisolism 1, 2
A serum sodium level of 131 mmol/L or lower merits evaluation and treatment, according to the Neurosurgery guidelines 1, 2

For severe symptomatic SIADH, the American College of Neurosurgery recommends administering 3% hypertonic saline with goal to correct 6 mmol/L over 6 hours or until severe symptoms resolve, with monitoring of serum sodium every 2 hours initially 1, 2, 4
Limit total correction to no more than 8-10 mmol/L in 24 hours to prevent osmotic demyelination syndrome, as recommended by the Neurosurgery guidelines 1, 2, 4
For mild/asymptomatic SIADH, fluid restriction to 1 L/day is the first-line treatment, according to the Praxis Medical Insights guidelines 4, 5, 6

CSW requires replacement of sodium and intravenously administered fluids, with the Neurosurgery guidelines recommending against using fluid restriction in CSW as this can worsen outcomes 1, 2, 4
Fludrocortisone may be used in hyponatremic subarachnoid hemorrhage (SAH) patients at risk for vasospasm, as recommended by the Neurosurgery guidelines 1, 2

In SAH patients with hyponatremia who are at risk for vasospasm, fluid restriction should be avoided, according to the Neurosurgery guidelines 1, 2, 4
Patients with advanced liver disease, alcoholism, or malnutrition require more cautious correction rates (4-6 mmol/L per day) due to higher risk of osmotic demyelination syndrome, as recommended by the Praxis Medical Insights guidelines 4
Hyponatremia itself contributes to neurological impairment and is not just a biomarker of illness severity, according to the Neurosurgery guidelines 1, 2, 3
A sodium level of 120 mmol/L is considered the critical threshold for development of seizures, as recommended by the Neurosurgery guidelines 1, 2

Correcting hyponatremia too rapidly (>10 mmol/L/day), especially in chronic hyponatremia, which can lead to central pontine myelinolysis and osmotic demyelinating syndrome, as warned by the Neurosurgery and Praxis Medical Insights guidelines 1, 2, 4
Using fluid restriction in CSW instead of SIADH, which can worsen outcomes, as warned by the Praxis Medical Insights guidelines 4

For severe symptoms: monitor serum sodium every 2 hours during initial correction, as recommended by the Praxis Medical Insights guidelines 4, 5
Watch for signs of osmotic demyelination syndrome (dysarthria, dysphagia, oculomotor dysfunction, quadriparesis) typically occurring 2-7 days after rapid correction, as recommended by the Praxis Medical Insights guidelines 4